» Articles » PMID: 36359825

Bioengineering Human Pluripotent Stem Cell-Derived Retinal Organoids and Optic Vesicle-Containing Brain Organoids for Ocular Diseases

Overview
Journal Cells
Publisher MDPI
Date 2022 Nov 11
PMID 36359825
Authors
Affiliations
Soon will be listed here.
Abstract

Retinal organoids are three-dimensional (3D) structures derived from human pluripotent stem cells (hPSCs) that mimic the retina's spatial and temporal differentiation, making them useful as in vitro retinal development models. Retinal organoids can be assembled with brain organoids, the 3D self-assembled aggregates derived from hPSCs containing different cell types and cytoarchitectures that resemble the human embryonic brain. Recent studies have shown the development of optic cups in brain organoids. The cellular components of a developing optic vesicle-containing organoids include primitive corneal epithelial and lens-like cells, retinal pigment epithelia, retinal progenitor cells, axon-like projections, and electrically active neuronal networks. The importance of retinal organoids in ocular diseases such as age-related macular degeneration, Stargardt disease, retinitis pigmentosa, and diabetic retinopathy are described in this review. This review highlights current developments in retinal organoid techniques, and their applications in ocular conditions such as disease modeling, gene therapy, drug screening and development. In addition, recent advancements in utilizing extracellular vesicles secreted by retinal organoids for ocular disease treatments are summarized.

Citing Articles

Single-cell sequencing in diabetic retinopathy: progress and prospects.

Yang T, Zhang N, Yang N J Transl Med. 2025; 23(1):49.

PMID: 39806376 PMC: 11727737. DOI: 10.1186/s12967-024-06066-x.


Optimized Prime Editing of Human Induced Pluripotent Stem Cells to Efficiently Generate Isogenic Models of Mendelian Diseases.

Cerna-Chavez R, Ortega-Gasco A, Azhar Baig H, Ehrenreich N, Metais T, Scandura M Int J Mol Sci. 2025; 26(1.

PMID: 39795970 PMC: 11719581. DOI: 10.3390/ijms26010114.


Organoids and organoid extracellular vesicles-based disease treatment strategies.

Zhou G, Li R, Sheng S, Huang J, Zhou F, Wei Y J Nanobiotechnology. 2024; 22(1):679.

PMID: 39506799 PMC: 11542470. DOI: 10.1186/s12951-024-02917-3.


Extracellular vesicles - on the cusp of a new language in the biological sciences.

Raposo G, Stahl P Extracell Vesicles Circ Nucl Acids. 2024; 4(2):240-254.

PMID: 38288044 PMC: 10824536. DOI: 10.20517/evcna.2023.18.


The Healthy and Diseased Retina Seen through Neuron-Glia Interactions.

Tempone M, Borges-Martins V, Cesar F, Alexandrino-Mattos D, de Figueiredo C, Raony I Int J Mol Sci. 2024; 25(2).

PMID: 38256192 PMC: 10817105. DOI: 10.3390/ijms25021120.


References
1.
Kimberling W, Hildebrand M, Shearer A, Jensen M, Halder J, Trzupek K . Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children. Genet Med. 2010; 12(8):512-6. PMC: 3131500. DOI: 10.1097/GIM.0b013e3181e5afb8. View

2.
VanderWall K, Huang K, Pan Y, Lavekar S, Fligor C, Allsop A . Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids. Stem Cell Reports. 2020; 15(1):52-66. PMC: 7363877. DOI: 10.1016/j.stemcr.2020.05.009. View

3.
Yu Y, Li L, Lin S, Hu J . Update of application of olfactory ensheathing cells and stem cells/exosomes in the treatment of retinal disorders. Stem Cell Res Ther. 2022; 13(1):11. PMC: 8751324. DOI: 10.1186/s13287-021-02685-z. View

4.
Knudsen E, Sexton C, Mayhew C . Role of the retinoblastoma tumor suppressor in the maintenance of genome integrity. Curr Mol Med. 2006; 6(7):749-57. DOI: 10.2174/1566524010606070749. View

5.
Marzano M, Bou-Dargham M, Cone A, York S, Helsper S, Grant S . Biogenesis of Extracellular Vesicles Produced from Human-Stem-Cell-Derived Cortical Spheroids Exposed to Iron Oxides. ACS Biomater Sci Eng. 2021; 7(3):1111-1122. PMC: 8185622. DOI: 10.1021/acsbiomaterials.0c01286. View